Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
07/2003
07/17/2003WO2002083928A3 Nucleid acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer
07/17/2003WO2002081646A3 Epitope sequences
07/17/2003WO2002072626A3 Novel form of the phgpx protein as a diagnostic marker for male infertility
07/17/2003WO2002059286A3 Adenylate cyclases
07/17/2003WO2002058323A3 Method for identifying modulators of bace
07/17/2003WO2002053774A3 Method for determining homeostasis of the skin
07/17/2003WO2002044201A3 Haplotypes of the sah gene
07/17/2003WO2002040715A3 Molecules for disease detection and treatment
07/17/2003WO2002040683A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
07/17/2003WO2002039947A3 Carrier vectors through an epithelium with tight junctions
07/17/2003WO2002038803A3 Novel marker for the diagnosis and therapy of tumours
07/17/2003WO2002031134A3 Novel serine protease genes related to dppiv
07/17/2003WO2002027021A3 Method for detecting fungal infections
07/17/2003WO2002026998A3 Hydrolases
07/17/2003WO2002022805A3 Modulation of il-2- and il-15-mediated t cell responses
07/17/2003WO2002018639A3 Detection of cyp2c19 polymorphisms
07/17/2003WO2002018625A3 Compositions and methods for detecting target microorganisms in a sample
07/17/2003WO2002017858A9 Role of fosb in bone formation
07/17/2003WO2002008469A3 Methods, systems, and articles of manufacture for evaluating biological data
07/17/2003WO2002002227A8 Devices and methods for carrying out chemical reactions using photogenerated reagents
07/17/2003WO2001096604A3 Assay for genetic polymorphisms using scattered light detectable labels
07/17/2003WO2001070943A3 Stable composition comprising a nuclease and a phosphatase
07/17/2003US20030135890 Nucleic acids that control plant development
07/17/2003US20030135888 Nucleotide sequences for controlling expression of RNA sequences in rice plants; antisense agents; genetic suppressor sequences
07/17/2003US20030135881 Quantitative trait loci associated with soybean cyst nematode resistance and uses thereof
07/17/2003US20030135873 Transgenic animal model coding fusion protein comprising nuclear protein and herpes viral vp16 protein; antidiabetic agents; uncoupling proteins
07/17/2003US20030135108 High throughput screening methods using magnetic resonance imaging agents
07/17/2003US20030135040 Such as 8-amino-2'deoxyadenosine by treating 8-azido-2'deoxyadenosine with aqueous solution of methylamine or dimethylamine; for targeting nucleic acids without amplification and less use of enzymes
07/17/2003US20030135039 Isolating nucleotide sequences from solid phase support comprising hydrophilic graft polymers by adsorbing/desorbing onto from support; for detecting and diagnosing human pathogens
07/17/2003US20030135038 Magnetic pigment
07/17/2003US20030135028 Human serine protease and serpin polypeptides
07/17/2003US20030135026 Compounds and methods for diagnosis of tuberculosis
07/17/2003US20030135025 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134865 Modulation of histone deacetylase
07/17/2003US20030134829 X is a ring having at least 4 atoms in the ring; K is hydrocarbyl group; Rh1 is an optional halo group; Rh2 is an optional halo group; at least one of Rh1 and Rh2 is present; Rs is any one of a sulphamate group, a phosphonate,
07/17/2003US20030134812 Bladder and lower urinary tract syndromes, particularly, irrative symptoms, and to a method of treating same using alpha 1d-adrenergic receptor ( alpha 1dAR) antagonists. The invention further relates to a method of screening compounds
07/17/2003US20030134807 Enzymatic nucleic acid synthesis: compositions and methods for altering monomer incorporation fidelity
07/17/2003US20030134791 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134788 Human tumor necrosis factor receptor TR16
07/17/2003US20030134785 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134784 A novel gene (designated 83P2H3) and its encoded protein are described. While 83P2H3 exhibits tissue specific expression in normal adult tissue, it is aberrantly expressed in prostate cancer. 83P2H3 provides a diagnostic and/or theraputic target
07/17/2003US20030134776 Methods for predicting drug sensitivity in patients afflicted with an inflammatory disease
07/17/2003US20030134431 Includes microfluidic channels and electroosmosis for fluorescent detection and monitoring receptor/ligand interactions on substrates; immunoassays; drug screening
07/17/2003US20030134430 Novel amino acid sequences for human caenorhabditis elegans-like protein polypeptides
07/17/2003US20030134410 For nucleic acid hybridization reactions on substrates having flexible coverings; disease diagnosis
07/17/2003US20030134386 A fibronectin type III (Fn3) monobody polypeptide consisting of two to six beta -strand domains with a loop region linked between each beta-strand domain, and such polypeptide is capable of binding to a target molecule
07/17/2003US20030134385 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134384 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134383 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134382 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134381 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134380 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134379 Nucleic acid molecule comprising a nucleotide sequence that encodes a PRO polypeptide
07/17/2003US20030134378 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134377 Nucleic acid molecule comprising a nucleotide sequence that encodes a PRO polypeptide
07/17/2003US20030134376 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134375 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134374 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134373 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134372 Nucleic acid molecule comprising a nucleotide sequence that encodes a PRO polypeptide
07/17/2003US20030134370 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134369 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134368 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134367 Vectors with DNA encoding pro polypeptides
07/17/2003US20030134366 Vectors with DNA encoding pro polypeptides
07/17/2003US20030134365 Vectors with DNA encoding pro polypeptides
07/17/2003US20030134364 Vectors with DNA encoding pro polypeptides
07/17/2003US20030134363 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134362 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134361 Vectors with DNA encoding pro polypeptides
07/17/2003US20030134360 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134359 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134358 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134357 Vectors with DNA encoding pro polypeptides
07/17/2003US20030134356 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134355 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134354 Vectors with DNA encoding pro polypeptides
07/17/2003US20030134350 Zinc finger domain recognition code and uses thereof
07/17/2003US20030134349 Enzymes for the detection of nucleic acid sequences
07/17/2003US20030134348 Recombinant bioluminescent bacteria Escherichia coli DH5@/pSodaLux (EBHJ1) [KCTC 10098BP] for monitoring oxidative stress
07/17/2003US20030134347 Subcutaneous glucose electrode
07/17/2003US20030134343 Contacting a sample with an antibody or fragment having binding affinity for mucin, so a complex forms and isolating the complex; early diagnosis
07/17/2003US20030134337 Muscle sample prepared for prion assay
07/17/2003US20030134324 Identifying drugs for and diagnosis of Benign Prostatic Hyperplasia using gene expression profiles
07/17/2003US20030134322 Solid phase thermoplastic or thermosetting resin substrate having a DNA or RNA embedded therein for hybridization assays and immunoassays to detect antinucleic acid antibody
07/17/2003US20030134321 High resolution DNA detection methods and devices
07/17/2003US20030134320 Providing, from a first and second electrical signals corresponding to a first and second unprocessed image data and by first and second process, a first and second data, sets of biosamples, comparing both by a computer program code
07/17/2003US20030134319 Amino acid sequences of peptides that are encoded by genes within the human genome, the kinase peptides
07/17/2003US20030134318 Methods of using randomized libraries of zinc finger proteins for the identification of gene function
07/17/2003US20030134316 Method of stirring reaction solutions
07/17/2003US20030134315 Testing a sample from a cancer patient for the expression of a negative signal transduction factor (NSTF) and for the expression of a positive signal transduction factor (PSTF), selecting chemotherapeutic agent for treatment based on above
07/17/2003US20030134314 Assaying the ability of specific polypeptide activity, thereby identifying a compound capable of treating a hematologic disorder
07/17/2003US20030134312 Utilizes at least one primer for analysis; automatic for massed screening and the discovery of sequence variants of known virons, undetected virons and others
07/17/2003US20030134311 Isolation of tree genomic DNA from a spruce live tissue source, hybridization of the DNA probe to that genomic DNA and the densitometric assesment of the intensity of the hybridizatin pattern obtained; cloning
07/17/2003US20030134310 Cellular kinase targets and inhibitors, and methods for their use
07/17/2003US20030134309 Detection of hypermutable nucleic acid sequence in tissue
07/17/2003US20030134308 Bone morphogenic proteins (BMP), BMP receptors and BMP binding proteins and their use in the diagnosis and treatment of glaucoma
07/17/2003US20030134307 Improve the signal intensity, sensitivity, and quantitative nature of molecular beacons detection strategies, such as for real time polymerase chain reaction product detection
07/17/2003US20030134305 Toxicology; assessing DNA damaging potential of drugs undergoing clinical trials; evaluating patient-specific responses to chemotherapy or radiation therapy; evaluating compounds, diets, or other factors that may damage DNA
07/17/2003US20030134304 Spectrometric measurements of the samples of bio-fluid, evaluating multi data sets with multivariate analysis, determiing correaltion between one of the one or more sets of differences, developing profile of a biological system
1 ... 2084 2085 2086 2087 2088 2089 2090 2091 2092 2093 2094 2095 2096 2097 2098 2099 2100 2101 2102 2103 2104 ... 3003